Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccinations against bacterial infections.

H W Ocklitz

    Padiatrie Und Grenzgebiete
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Evaluating prophylactic vaccination requires balancing benefits against harms and costs. This review categorizes vaccines, discussing established, developing, and future bacterial infection prevention strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Observations of childhood typhus.

    Zeitschrift fur Kinderheilkunde·2010
    Same author

    [The clinico-diagnostic value of C-reactive protein, determined by simple radial immunodiffusion and compared with latex agglutination].

    Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete·1989
    Same author

    The effects of systematic BCG vaccination of newborn on the incidence of post-primary tuberculous meningitis in childhood.

    Padiatrie und Grenzgebiete·1989
    Same author

    [Congenital toxoplasmosis and Toxoplasma infection. Detection--therapy--prevention].

    Kinderarztliche Praxis·1987
    Same author

    [Preventive pertussis vaccination?].

    Kinderarztliche Praxis·1987
    Same author

    Meningococcal infections in the German Democratic Republic 1971-1984.

    Infection·1986

    Area of Science:

    • Immunology
    • Public Health
    • Bacteriology

    Background:

    • Vaccine evaluation balances benefits (morbidity/mortality reduction) against harms (side effects) and societal costs.
    • Current vaccine assessment ranges from eradication potential to heightened concern over side effects as diseases decline.

    Purpose of the Study:

    • To review current and potential vaccination strategies against bacterial infections.
    • To categorize vaccines into established, developing, and future feasibility classes.

    Main Methods:

    • Categorization of vaccines based on development stage and feasibility.
    • Discussion of specific bacterial targets and vaccine types.

    Main Results:

    • Class 1: Established vaccines (e.g., BCG, DPT) with ongoing debate on future use.

    Related Experiment Videos

  • Class 2: Newer vaccines in development (e.g., against meningococci, pneumococci, H. influenzae, E. coli).
  • Class 3: Vaccines with current feasibility challenges (e.g., against enterotoxins, syphilis, gonorrhea, hospital-acquired infections).

    • Conclusions:

    • Vaccination strategies are evolving, with ongoing research into new and improved bacterial infection preventatives.
    • The development of vaccines against challenging targets like enterotoxins and hospital-acquired pathogens remains a priority.